Font Size: a A A
Keyword [Sorafenib resistance]
Result: 21 - 40 | Page: 2 of 2
21. ATAD3A Mediates Sorafenib Insensitivity And Other Malignant Biological Behaviors Through Hypoxia-induced MiRNA-210-5p In Hepatocellular Carcinima
22. The Mechanism Of Long Noncoding RNA SNHG16 In Promoting The Proliferation And Sorafenib Resistance Of Hepatocellular Carcinoma Through Regulating MLXIP Via MiR-4458
23. Construction Of Compound Immunoliposomes Loaded With Melittin And Bufalin And Its Synergistic Mechanism In Inhibiting Sorafenib Resistance In Hepatocellular Carcinoma
24. Molecular Mechanism Of Sorafenib Resistance In Hepatocellular Carcinoma
25. Mechanism Studied Of Sorafenib Resistance In Hepatocellular Carcinoma Cells Induced By Activation Of Autophagy By Ubiquitin-like Protein FAT10
26. Study On Mechanisms Underlying The Involvement Of CIAP2 In HBV-induced Liver Cancer And Sorafenib Resistance
27. MiR-486-3p Mediates Hepatocellular Carcinoma Sorafenib Resistance By Targeting FGFR4 And EGFR
28. M6A Methylation-mediated FOXA3 Reduction Renders Hepatocellular Carcinoma Dedifferentiation And Sorafenib Resistance
29. Blockage Of The PI3k/Akt Signaling Pathway Reverses Sorafenib-derived Chemo-resistance In Hepatocellular Carcinoma
30. The Role And Molecular Mechanism Of PRMT5 In Sorafenib Resistance In Liver Cancer
31. Based On The Regulation Mechanism Of MiR-21/miR-122, The Effect Of Yiqi Huayu Jiedu Decoction On The Resistance Of Sorafenib To Human Liver Cancer QGY 7702 Cells Was Studied
32. Identification And Regulation Mechanism Of Nek2 In Hepatocellular Carcinoma Sorafenib Resistance
33. MiR-194 Inhibits Liver Cancer Stem Cell Expansion By Regulating RAC1 And Predicts The Prognosis Of HCC Patients
34. The Function And Mechanism Of KIAA1199 Regulating Sorafenib Resistance In Hepatocellular Carcinoma
35. The Mechanism Of MiR-425 Regulates Lipophagy Via SIRT1 To Promote Sorafenib Resistance In Hepatocellular Carcinoma Cells
36. Mettl3/m6a/DUXAP8 Axis Induces Sorafenib Resistance Mechanism In Hepatocellular Carcinoma Through Activation Of MAPK/ERK Pathway
37. The Role And Mechanism Of LncRNA HCP5 In Renal Cell Carcinoma Cells With Sorafenib Resistance
38. The Role Of IL-6 And Related Mechanisms In Metastasis And Sorafenib Resistance Of Hepatocellular Carcinoma
39. Interaction Between Cdc20 And GRP78 Activating ERK Induces Sorafenib Resistance In HCC
40. CISD2 Promotes Resistance To Sorafenib-induced Ferroptosis By Regulating Beclin1-dependent Autophagy In Hepatocellular Carcinoma Cells
  <<First  <Prev  Next>  Last>>  Jump to